[Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), reported transactions on 08/13/2025. The filing shows acquisition of 11,581 shares at an exercise price of $5.01 and a contemporaneous sale of 11,581 shares at a weighted average price of $48.0459, with sales executed in the range $47.84–$48.32. The report also records a transfer of 62,722 Class A shares from the Oluyemi Okupe Separate Property Trust dated 9-1-2021 to the reporting person’s direct holdings. Post-transaction direct beneficial ownership is reported as 65,665 Class A shares. The exercised options referenced vest per a schedule beginning January 24, 2023, with full monthly vesting thereafter and expire February 23, 2032.

Positive

• Transparent disclosure of exercise, sale, and transfer details including price range and vesting schedule
• Use of a 10b5-1 plan (checked on form) indicating transactions were executed under a pre-established plan
• Transfer from trust to direct holdings increases direct ownership visibility (62,722 shares transferred)

Negative

• Insider sale of shares by the CFO reduces his direct trading stake by 11,581 shares
• Material proceeds realized from sale could be perceived as insider monetization (exercise price $5.01 vs sale weighted-average $48.0459)

Insights

Financial Analyst

TL;DR: CFO exercised options and immediately sold the exercised shares, realizing material value per disclosed prices.

The Form 4 documents an option exercise and a same-day sale of 11,581 Class A shares by the CFO. The exercise price of $5.01 versus the reported weighted-average sale price of $48.0459 implies the insider monetized equity created by prior option grants. The transaction reduces the CFO's direct holdings by the sold amount but was partially offset by a transfer from a family trust, leaving 65,665 shares directly held. The disclosed vesting schedule and long expiration date indicate these options were standard employee awards with multi-year service vesting conditions.

Corporate Governance Expert

TL;DR: Transaction appears routine under a documented plan with vesting and trust transfer; timely disclosure was made.

The filer checked the box indicating the sale was pursuant to a Rule 10b5-1 plan, suggesting pre-planned execution. The filing includes the required explanatory notes about sale price range and a trust-to-direct transfer of 62,722 shares. Vesting details for the options are disclosed, including the 12-month cliff and monthly vesting thereafter. From a governance perspective, the Form 4 meets standard disclosure elements for insider option exercise, sale, and transfers.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Okupe Oluyemi

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/13/2025		M		11,581	A	$5.01	65,665	D
Class A Common Stock	08/13/2025		S		11,581	D	$48.0459(1)	116,806(2)	D
Class A Common Stock								7,853(2)	I	Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$5.01	08/13/2025		M			11,581	(3)	02/23/2032	Class A Common Stock	11,581	$0	361,365	D

Explanation of Responses:

1. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $47.84 - $48.32. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

2. The balance reflects a transfer of 62,722 shares of Class A Common Stock held by the Oluyemi Okupe Separate Property Trust dtd 9-1-2021 to the Reporting Person's direct holdings.

3. 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Remarks:

	/s/ Alexandra Cotter Wilkins, Attorney-in-Fact	08/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did HIMS CFO Oluyemi Okupe transact on 08/13/2025?

He acquired and sold 11,581 Class A shares on 08/13/2025: an acquisition via option exercise at $5.01 and a sale at a weighted-average price of $48.0459.

Were the shares sold under a trading plan for HIMS (ticker HIMS)?

Yes. The filer checked the box indicating the transaction was made pursuant to a Rule 10b5-1 plan.

Did the filing show any transfers from a trust to direct holdings?

Yes. The filing reports a transfer of 62,722 Class A shares from the Oluyemi Okupe Separate Property Trust dated 9-1-2021 to the reporting person.

What is the post-transaction direct beneficial ownership reported?

65,665 Class A shares are reported as directly beneficially owned following the transactions.

What are the vesting and expiration details for the reported options?

Vesting: 25% on the 12-month anniversary of January 24, 2022, then monthly over 36 months; Expiration: February 23, 2032.